StockData
Cardio Diagnostics Holdings, Inc. logo

Cardio Diagnostics Holdings, Inc. (CDIO) income statement

CDIONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIOW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$1.71−0.08 (-4.47%)

Close on Nov 17, 2026Market cap $5.06MP/E –Yield –

Cardio Diagnostics Holdings, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-43737.5%
Net margin
-43832.5%
Return on equity, FY2025
-78.6%

Financial strength

Current ratio
17.15
Debt to equity
–
Debt to assets
–
Cash to current liabilities
0.0%

Valuation

P/E ratio
–
Price to sales
341.36
Price to book
0.68
Dividend yield
–

See a number that looks wrong?